Insider Stock Trading History of Rowinsky Eric K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rowinsky Eric K since year 2005. The trader's CIK number is 1318886. At the time of this reporting, Rowinsky Eric K is the Director of Bind Therapeutics, Inc . (stock ticker symbol BIND). See this page for all insider trading activities at Bind Therapeutics, Inc .

Note that in the past Rowinsky Eric K also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Rowinsky Eric K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-29 BIND Bind Therapeutics, Inc Option Ex 15,000 .44 6,600
2015-04-27 STML Stemline Therapeutics Inc Sale 10,824 15.77 170,694
2015-03-20 BIIB Biogen Idec Inc Option Ex 11,667 59.82 697,919
2015-03-20 BIIB Biogen Idec Inc Sale 11,667 475.00 5,541,825
2015-03-19 BIIB Biogen Idec Inc Option Ex 2,333 59.82 139,560
2015-03-19 BIIB Biogen Idec Inc Sale 2,333 436.14 1,017,507
2015-03-17 BIIB Biogen Idec Inc Option Ex 4,667 59.82 279,179
2015-03-17 BIIB Biogen Idec Inc Sale 4,667 425.45 1,985,589
2015-03-09 BIIB Biogen Idec Inc Option Ex 4,666 59.82 279,120
2015-03-09 BIIB Biogen Idec Inc Sale 4,666 417.23 1,946,795
2015-02-18 STML Stemline Therapeutics Inc Sale 1,640 13.99 22,943
2014-04-25 STML Stemline Therapeutics Inc Sale 11,179 15.36 171,653
2014-01-21 BIIB Biogen Idec Inc Sale 2,020 310.09 626,381
2013-11-25 STML Stemline Therapeutics Inc Sale 13,903 20.56 285,845
2012-01-06 BIIB Biogen Idec Inc Option Ex 12,992 59.82 777,181
2012-01-06 BIIB Biogen Idec Inc Sale 12,992 116.00 1,507,072
2011-08-19 NEOP Neoprobe Corp Buy 15,000 2.55 38,250
2008-02-15 IMCL Imclone Systems Inc/de Option Ex 2,667 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rowinsky Eric K (Director of Bind Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.